Chang W W
J Natl Cancer Inst. 1978 Jun;60(6):1405-18. doi: 10.1093/jnci/60.6.1405.
CF-1 female adult mice were given weekly sc injections of 20 mg symmetrical 1,2-dimethylhydrazine (DMH)-2HCl/kg body weight and killed at various intervals after commencement of the injection. [3H]thymidine (TdR) was given before the animals were killed. The histogenesis of colon neoplasms was investigated by means of autoradiographs prepared from sections of Epon-embedded descending colon, which were stained with periodic acid-Schiff reaction and iron hematoxylin. By 9 weeks after initiation of DMH treatment, the distal 5 cm of the colon became enlarged, the mucosa thickened, and the crypts were elongated and hyperplastic. In the hyperplastic crypts, the number of proliferating cells increased, but the distribution of these cells followed a previously discussed slow cut-off model of Cairnie et al. as for the normal crypts. Differentiation and transformation of epithelial cells occurred, but somewhat aberrantly. Hyperplasia of the crypts occurred diffusely, but neoplastic lesions that began to appear by 9 weeks after the intiial treatment were isolated. An isolated crypt from which a neoplasm developed was first repopulated by what appeared to be altered, undifferentiated "stem" cells. These cells did not differentiate, continued to divide, and eventually upon migration accumulated in the upper part of the crypts, where an earliest identifiable neoplastic lesion was observed. Once such a lesion was formed, it expanded in various directions, depending on the local environments, and formed a polypoid or discoid lesion. The biologic behavior of the neoplasm seemed to be determined by the downward progression of its leading edge. When it penetrated the muscularis mucosae, the neoplasm became highly invasive. In the murine model, the invasive adenocarcinomas were observed by 26 weeks after commencement of DMH treatment.
给CF-1成年雌性小鼠每周皮下注射20毫克对称1,2 - 二甲基肼(DMH)-2HCl/千克体重,并在注射开始后的不同时间点处死。在处死动物前给予[³H]胸腺嘧啶核苷(TdR)。通过对环氧树脂包埋的降结肠切片制备的放射自显影片进行研究,这些切片用高碘酸 - 希夫反应和铁苏木精染色,以观察结肠肿瘤的组织发生过程。在DMH治疗开始后9周,结肠远端5厘米处开始增大,黏膜增厚,隐窝拉长且增生。在增生的隐窝中,增殖细胞数量增加,但这些细胞的分布遵循先前讨论的Cairnie等人关于正常隐窝的缓慢截止模型。上皮细胞发生分化和转化,但存在一定异常。隐窝增生弥漫性发生,但在初始治疗后9周开始出现的肿瘤性病变是孤立的。一个发生肿瘤的孤立隐窝首先由似乎是改变的、未分化的“干细胞”重新填充。这些细胞不分化,继续分裂,最终在迁移后聚集在隐窝上部,在那里观察到最早可识别的肿瘤性病变。一旦形成这样的病变,它会根据局部环境向各个方向扩展,形成息肉样或盘状病变。肿瘤的生物学行为似乎由其前沿的向下进展决定。当它穿透黏膜肌层时,肿瘤变得具有高度侵袭性。在小鼠模型中,DMH治疗开始后26周观察到侵袭性腺癌。